mRNA Vaccine for Flu
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate the immunogenicity and safety of updated strain-containing compositions of the mRNA-1010 vaccines within the current epidemiological environment.
Are You a Good Fit for This Trial?
This trial is for adults who can give informed consent and, if female, are not able to become pregnant. Participants should be generally healthy and willing to follow study rules.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- mRNA-1010
Trial Overview
The study compares an updated mRNA flu vaccine (mRNA-1010) with a standard high-dose seasonal flu shot. It looks at how well each vaccine works and their safety in the current flu season.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will receive a single dose of mRNA-1010 by intramuscular (IM) injection on Day 1.
Participants will receive a single dose of licensed high-dose seasonal influenza vaccine by IM injection on Day 1.
Find a Clinic Near You
Who Is Running the Clinical Trial?
ModernaTX, Inc.
Lead Sponsor
Dr. Stephen Hoge
ModernaTX, Inc.
Chief Medical Officer
MD from Harvard Medical School
Stéphane Bancel
ModernaTX, Inc.
Chief Executive Officer since 2011
MBA from Harvard Business School, MSc in Engineering from École Centrale Paris
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.